Media & Analysis

News
David Munis Zepernick

David Munis Zepernick

Head of Business Development and Public Affairs

Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.

MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.

If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.

The microbiome – a new way to cure diseases and an increasingly stronger research area in Greater Copenhagen

Danish financial daily, Børsen, and, Øresund News, are among the media, which have highlighted the true potential of the  interregional EU project, Greater Copenhagen Microbiome Signature Project led by Medicon Valley Alliance, together with Copenhagen Capacity and Invest in Skåne, with the aim of positioning the life sciences cluster Medicon Valley as a global centre for microbiome research by attracting foreign companies and talent to the region. The project has identified over 80...

Novo Nordisk Scandinavia joins Medicon Valley Alliance

Medicon Valley Alliance is very happy indeed to welcome Novo Nordisk Scandinavia and General Manager & VP, Novo Nordisk Scandinavia, Niels Abel Bonde to the +300 member strong Danish-Swedish MVA-family. "We consider it a strategic priority to be a part of the Swedish and Medicon Valley based life science eco-system. Medicon Valley Alliance is working constructively to create better framework conditions for life science companies in the region, which is something we would also like to...

The Royal Swedish Academy of Sciences awards the Nobel Prize in Chemistry to female genome editing pioneers Emmanuelle Charpentier and Jennifer A. Doudna.

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier, Max Planck Unit for the Science of Pathogens, Berlin, Germany and Jennifer A. Doudna, University of California, Berkeley, USA, for their development of a method for genome editing Emmanuelle Charpentier and Jennifer A. Doudna have discovered one of gene technology’s sharpest tools: the CRISPR/Cas9 genetic scissors. Using these, researchers can change the DNA of animals,...

“Think big and pick the low-hanging fruits” – business column by MVA, chairman, Søren Bregenholt, in Copenhagen Post

The COVID-19 outbreak has understandably catapulted healthcare and life science to the very top of the political agenda for at least two different reasons. In today´s Copenhagen Post business column you can read what they are and why and how Medicon Valley, Danish-Swedish life science, and innovation in the Nordics could all benefit, if we think big and pick the low-hanging fruits.

Digital Health – A new Nordic Stronghold

In the print and online magazine, Nordic Business, published this week, MVA Head of Business Development & Public Affairs, David Munis Zepernick, highlights the potential of digital health as a new Nordic life science stronghold. Digital health is a cornerstone of both the newer Danish and Swedish national life science strategies and in the broader public health strategies and Denmark and Sweden, both consistently ranked in the top 10 in virtually any ranking of the use of e-health...

MVA-member, 2CureX, presents at ESMO Virtual Congress 2020 (European Society for Medical Oncology)

Anyone who is anyone within the field of medical oncology was supposed to be in Madrid these days for the  ESMO Congress 2020. This goes for MVA-member company, 2CureX, as well, but like so many other international life science conferences, ESMO has had to think out of the box this year due to COVID-19 and go virtual. But how do you give a convincing digital demonstration of your company, tell your story and get your messages across in the new digital reality that many of us will now have to...

MVA-member, BioInnovation Institute, awards EUR 14M to eight innovative and promising start-ups and research projects

The start-ups and research projects work within the three life science industries: therapeutics, health tech and bioindustrials. The start-ups and projects are developing a diverse range of products and solutions ranging from using an innovative approach to using CRISPR Cas-12 variants to be safely used in gene-editing, a new amyotrophic lateral sclerosis (ALS) treatment, a gut approach to treating osteoporosis, a range of biological products against aquatic pests and diseases, and the...

Don´t miss the recently released video interview with MVA-member company, Scandion Oncology´s, new CEO, Bo Rode Hansen

See the interview with new CEO of MVA-member, Scandion Oncology, Bo Rode Hansen, and former CEO - now CSO - , Nils Brünner, in BioStock.se about the recent changes in the company´s top management. A Danish company interviewed by a Swedish media in English. Just the way we like it in Medicon Valley! See full interview here, where you will also get a very clear and concise answer to the question whether Nils Brünner (who also happens to be one of the founding fathers of the MVA Oncology Network)...

MVA-member, Zealand Pharma, builds Global Medical Affairs function with world-renowned experts

Dr. Danilo Verge and Dr. David Kendall, both of whom have decades of experience in the global diabetes space, have joined Zealand Pharma. As Head of Global Medical Affairs at Zealand Pharma, Dr. Danilo Verge will be responsible for all medical activities worldwide related to Zealand Pharma’s metabolic and gastrointestinal franchises including dasiglucagon, glepaglutide and V-Go®. He brings over 20 years of experience from having built and led Medical Affairs functions. Dr. David Kendall has...

MEDICON VALLEY ALLIANCE MEMBER, CHR. HANSEN, WILL CONTINUE TO PIONEER MICROBIAL SCIENCE TO IMPROVE FOOD AND HEALTH, FOR A MORE SUSTAINABLE FUTURE AS PART OF NEW 2025 STRATEGY

MVA-member company, Chr. Hansen, has just released their new ambitious 2025 strategy with the ambition to create a differentiated bioscience leader to improve food and health for a sustainable future In the press release published this week, CEO Mauricio Graber says: “Chr. Hansen has undertaken a tremendous journey since its start as an ingredient supplier to the dairy industry, and I feel very proud to lead a company with such a strong purpose...